Evidence map›Paper›PMID 28262821›Full record

ArticleScientific reports2017

Notch Ligand DLL4 Alleviates Allergic Airway Inflammation via Induction of a Homeostatic Regulatory Pathway.

Miao-Tzu Huang, Yi-Lien Chen, Chia-I Lien, Wei-Liang Liu, Li-Chung Hsu, Hideo Yagita, Bor-Luen Chiang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. iScience · 2022
    Article
  8. Asthma in the Precision Medicine Era: Biologics and Probiotics.International journal of molecular sciences · 2021
    Review
  9. Review
  10. Review
  11. Article
  12. Emodin Alleviates the Airway Inflammation of Cough Variant Asthma in Mice by Regulating the Notch Pathway.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  13. Multi-Faceted Notch in Allergic Airway Inflammation.International journal of molecular sciences · 2019
    Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Miao-Tzu HuangDepartment of Medical Research, National Taiwan University Hospital, Taipei, 100, Taiwan.
Yi-Lien ChenGraduate Institute of Clinical Medicine, School of Medicine, National Taiwan University, Taipei, 100, Taiwan.
Chia-I LienGraduate Institute of Molecular Medicine, School of Medicine, National Taiwan University, Taipei, 100, Taiwan.
Wei-Liang LiuGraduate Institute of Clinical Medicine, School of Medicine, National Taiwan University, Taipei, 100, Taiwan.
Li-Chung HsuGraduate Institute of Molecular Medicine, School of Medicine, National Taiwan University, Taipei, 100, Taiwan.
Hideo YagitaDepartment of Immunology, Juntendo University School of Medicine, Tokyo, Japan.
Bor-Luen ChiangDepartment of Medical Research, National Taiwan University Hospital, Taipei, 100, Taiwan.
National Taiwan University · TWJuntendo University · JPNational Taiwan University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Notch is a pleiotropic signaling family that has been implicated in pathogenesis of allergic airway diseases; however, the distinct function of individual Notch ligands remains elusive. We investigated whether Notch ligands, Jagged1 and DLL4, exert differential effects in OVA-induced allergic asthma. We found that whilst Jagged1 inhibition mitigated Th2-dominated airway inflammation, blockage of DLL4 aggravated the Th2-mediated asthma phenotypes. Additionally, Jagged1 signaling blockage enhanced IL-17 production and neutrophilic airway infiltration. In vitro, exogenous Jagged1 induced Th2-skewed responses, whereas augmented DLL4 signaling displayed a dual role by promoting expansion of both Tregs and Th17. In vivo, DLL4 blockage impaired Treg differentiation which plausibly resulted in exaggerated asthma phenotypes. On the contrary, administration of DLL4-expressing antigen-presenting cells promoted endogenous Treg expansion and ameliorated the allergic responses. Therefore, whilst Jagged1 induces Th2-skewed inflammation, DLL4 elicits an essential self-regulatory mechanism via Treg-mediated pathway that counterbalances Jagged1-induced Th2 responses and facilitates resolution of the airway inflammation to restore homeostasis. These findings uncover a disparate function of Jagged1 and DLL4 in allergic airway diseases, hinting feasibility of Notch ligand-specific targeting in therapy of allergic airway diseases.

Indexed as

Signal TransductionAllergensAnimalsAntibodiesAsthmaBiomarkersCytokinesDisease Models, AnimalFemaleHomeostasisIntracellular Signaling Peptides and ProteinsJagged-1 ProteinLymphocyte ActivationMembrane ProteinsMiceMice, TransgenicAllergensAntibodiesBiomarkersCytokinesdelta proteinIntracellular Signaling Peptides and ProteinsJagged-1 ProteinMembrane ProteinsReceptors, Notch

Identifiers

PMID28262821
PMCPMC5337933
OpenAlexW2592348189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.